[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349816-105":59,"doc-detail-349816-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","anti-colorectal-cancer-effects-of-irx4-and-sensitivity-studies-to-oxaliplatin","Anti-colorectal cancer effects of IRX4 and sensitivity studies to oxaliplatin","","Colorectal cancer (CRC) remains highly lethal, and loss of chemosensitivity is a major cause of chemotherapy failure in advanced disease. This study investigates Iroquois homeobox protein 4 (IRX4) as a potential regulator of CRC progression and oxaliplatin responsiveness. IRX4 expression and DNA methylation were assessed in CRC tissues and cell lines, followed by functional analyses of proliferation, invasion, migration, apoptosis, and chemosensitivity. Mechanistic work links IRX4 to suppression of the NF-kB/EGFR axis.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/anti-colorectal-cancer-effects-of-irx4-and-sensitivity-studies-to-oxaliplatin/349816/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/anti-colorectal-cancer-effects-of-irx4-and-sensitivity-studies-to-oxaliplatin/349816.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"Which pathway is proposed as the underlying mechanism?","Question",{"text":112,"@type":113},"The data suggest IRX4 suppresses TNF-α-induced NF-kB transcriptional activity and blocks NF-kB p65 nuclear translocation, thereby downregulating the NF-kB/EGFR pathway.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},349816,1790198645,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":131,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":132,"faqs":133,"seo_title":134,"seo_description":67,"update_tm":135,"read_time":31,"preview_page_count":19,"preview_urls":136},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","TYPE Original Research PUBLISHED 21 January 2026  \nDOI 10.3389/fimmu.2025.1581244  \nOPEN ACCESS  \nEDITED BY  \nZhiwen Luo,  \nFudan University, China  \nREVIEWED BY  \nRaphael Carmo Valente,  \nUniversidade Federal do Rio de JaneiroCampus Duque de Caxias Professor Geraldo Cidade, Brazil  \nXun Lin,  \nPﬁzer, United States  \n*CORRESPONDENCE  \nYabin Liu  \n [liuyabin@hebmu.edu.cn](liuyabin@hebmu.edu.cn)[ ](liuyabin@hebmu.edu.cn)Peng Kong  \n [pengkong@hebmu.edu.cn](pengkong@hebmu.edu.cn)  \nRECEIVED 21 February 2025  \nREVISED 15 December 2025  \nACCEPTED 29 December 2025  \nPUBLISHED 21 January 2026  \nCORRECTED 03 March 2026  \nCITATION  \nJia M, Kong D, Fan J, Heng B, Zhao J, Li B, Liu S, Kong P and Liu Y (2026)  \nAnti-colorectal cancer effects of IRX4 and sensitivity studies to oxaliplatin.  \nFront. Immunol. 16:1581244 .  \ndoi: 10.3389/fimmu.2025.1581244  \nCOPYRIGHT  \n© 2026 Jia, Kong, Fan, Heng, Zhao, Li, Liu, Kong and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nAnti-colorectal cancer effects of IRX4 and  \nsensitivity studies to oxaliplatin  \nMei Jia 1, Dexian Kong 2, Jiaxu Fan 1, Bingqian Heng 1, Jian Zhao 3, Binghui Li 1, Shuang Liu 4, Peng Kong 5* and Yabin Liu 1*  \n1 Department of General Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China, 2 Department of Endocrinology, Fourth Afﬁliated Hospital, Hebei Medical University,  \nShijiazhuang, China, 3Obstetrics and Gynecology Department, Shijiazhuang People's Hospital, Shijiazhuang, Hebei, China, 4General Surgery Department, Bethune International Peace Hospital, Shijiazhuang, Hebei, China, 5 Department of Biochemistry and Molecular Biology, College of Basic Medicine, Key Laboratory of Neural and Vascular Biology of Ministry of Education, Key Laboratory of Vascular Biology of Hebei Province, Hebei Medical University, Shijiazhuang, China  \nIntroduction: Colorectal cancer (CRC) remains one of the most lethal malignancies globally. Chemoresistance or reduced chemosensitivity is a key factor contributing to treatment failure in CRC, particularly in patients with advanced-stage disease. Iroquois homeobox protein 4 (IRX4), a transcription factor expressed in multiple tissues, has been demonstrated to be implicated in the progression of many cancers. Based on this background, IRX4 identiﬁed through Illumina Inﬁnium 935Kmethylation chip analysis was chosen to explore its potential role in CRC. Methods: Following initial screening via the Illumina Inﬁnium 935K methylation chip, we further conﬁrmed the hypermethylation of IRX4 in CRC tissues using pyrosequencing technology. The expression levels of IRX4 were determined by immunoﬂuorescence (IF) staining, reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and western blot (WB) assays. In vitro cell experiments evaluated the effects of IRX4 overexpression on the proliferation, invasion, migration, and apoptosis of CRC cells, as well as its impact on the chemosensitivity to oxaliplatin (OXA) . Mechanistically, after IRX4 overexpression, the phosphorylation level of epidermal growth factor receptor (EGFR) in CRC cells was detected. Luciferase reporter gene assays and immunoﬂuorescence staining were used to investigate the effects of IRX4 overexpression on the activation of the nuclear factor-kB (NF-kB) pathway and the nuclear translocation of the p65 subunit.  \nResults: IRX4 was downregulated in CRC tissues and cell lines, and its expression was negatively correlated with tumor invasion depth and poor prognosis. In vitro experiments demonstrated that the overexpression of IRX4 inhibited CRC cell prolife","cbCaib46Sa5COds7","https://ap.wps.com/l/cbCaib46Sa5COds7","pdf",24633266,"English","# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"Which pathway is proposed as the underlying mechanism?\",\"answer\":\"The data suggest IRX4 suppresses TNF-α-induced NF-kB transcriptional activity and blocks NF-kB p65 nuclear translocation, thereby downregulating the NF-kB/EGFR pathway.\"}]","Anti-colorectal cancer effects of IRX4 and sensitivity studies to oxaliplatin | PDF",1790085731,[137,141,145,149],{"page_no":8,"url":138,"width":139,"height":140},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/302ce953291910e365a92c0083f91982.webp",983,1389,{"page_no":14,"url":142,"width":143,"height":144},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96f8b24803ee1f30541c21475c6d2b01.webp",982,1388,{"page_no":81,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b202a6ca71e7e3eccab56645af600a61.webp",981,1386,{"page_no":19,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7a60ecbe81fcf22225379a5a5ad0ff0a.webp",980,1385]